NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions

The introduction of non-vitamin K antagonists oral anticoagulants, a class of medicines which includes dabigatran, apixaban, edoxaban and rivaroxaban, has resulted in improvements in the safety and efficacy of non valvular atrial fibrillation treatment for stroke prevention, with significant reducti...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Cesare, Mariachiara, Jarvis, Jordan D., Scarlatescu, Oana, Leng, Xinyi, Zaidel, Ezequiel J., Burrone, Esteban, Eiselé, Jean-Luc, Prabhakaran, Dorairaj, Sliwa, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2020
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546116/
https://www.ncbi.nlm.nih.gov/pubmed/33150132
http://dx.doi.org/10.5334/gh.774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546116/
https://www.ncbi.nlm.nih.gov/pubmed/33150132
http://dx.doi.org/10.5334/gh.774

Ejemplares similares